Lucence Company

Lucence is a company that produces Liquid Biopsy Tests for cancer detection and treatment. These tests are ultrasensitive and non-invasive, requiring only a single draw of blood.

Technology: diagnostics
Headquarters: Singapore
Funding Status: Early Stage Venture
Founded Date: 42461
Last Funding Type: Series A
Investors Number: 5
Last Funding Date: 2019-11-20
Estimated Revenue: $10M to $50M
Employee Number: 11-50
Total Funding: $29.2M
Industry: Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Investor Type: For Profit